Data / Drug companies / Quinolone Antimicrobial
Quinolone Antimicrobial drugs: 18 drugs from 44 companies in the FDA NDC directory
Quinolone Antimicrobial is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 120 products in this class from 44 companies, covering 18 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 15, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 44Companies
- 120Products
- 18Drugs by generic name
Drugs in the Quinolone Antimicrobial class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Ciprofloxacin | 10 | 41 |
| Ciprofloxacin hydrochloride | 7 | 36 |
| Ofloxacin | 65 | 26 |
| Moxifloxacin hydrochloride | 1 | 20 |
| Moxifloxacin | 2 | 19 |
| Ofloxacin otic | 16 | 10 |
| Ciprofloxacin hydrochloride and hydrocortisone | 1 | 5 |
| Besifloxacin | 4 | 3 |
| Gatifloxacin | 3 | 3 |
| Moxifloxacin hydrochloride tablets, 400 mg | 1 | 3 |
| Moxifloxacin ophthalmic | 1 | 3 |
| Ofloxacin ophthalmic solution usp, 0.3% | 3 | 2 |
| Finafloxacin | 1 | 1 |
| Gatifloxacin ophthalmic solution 0.5% | 1 | 1 |
| Ofloxacin ophth soln | 1 | 1 |
| Ofloxacin ophthalmic | 1 | 1 |
| Ofloxacin otic solution | 1 | 1 |
| Olfoxacin otic soln | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 10 | solution; solution/ drops | Generic drugs (ANDA) | December 1, 2023 |
| NuCare Pharmaceuticals,Inc. | 10 | solution/ drops; solution | Generic drugs (ANDA) | July 15, 2024 |
| Proficient Rx LP | 9 | solution/ drops; tablet | Generic drugs (ANDA) | December 15, 2014 |
| Remedyrepack Inc. | 6 | solution; solution/ drops | Generic drugs (ANDA) | September 16, 2026 |
| Caplin Steriles Limited | 5 | solution/ drops; solution | Generic drugs (ANDA) | October 6, 2025 |
| Proficient Rx LP | 5 | solution; tablet, film coated | Generic drugs (ANDA) | August 12, 2020 |
| Asclemed USA, Inc. | 4 | solution; suspension/ drops | Generic drugs (ANDA) | July 15, 2022 |
| Lifestar Pharma LLC | 4 | solution; solution/ drops | Generic drugs (ANDA) | August 25, 2023 |
| Preferred Pharmaceuticals Inc. | 4 | solution/ drops; solution | Generic drugs (ANDA) | March 17, 2026 |
| Sportpharm LLC | 4 | solution; suspension | Generic drugs (ANDA) | January 9, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | 3 | tablet, film coated | Generic drugs (ANDA) | October 10, 2009 |
| Bausch & Lomb Incorporated | 3 | solution; solution/ drops | Generic drugs (ANDA) | May 28, 2009 |
| Cadila Pharmaceuticals Limited | 3 | tablet, film coated | Generic drugs (ANDA) | December 29, 2015 |
| Direct_Rx | 3 | solution; solution/ drops | Generic drugs (ANDA) | June 8, 2023 |
| Leading Pharma, LLC | 3 | solution | Generic drugs (ANDA) | October 6, 2025 |
| Modavar Pharmaceuticals LLC | 3 | tablet, film coated | Generic drugs (ANDA) | June 24, 2025 |
| Redpharm Drug | 3 | solution; solution/ drops | Generic drugs (ANDA) | October 31, 2024 |
| Somerset Therapeutics, LLC | 3 | solution/ drops | Generic drugs (ANDA) | October 31, 2024 |
| Altaire Pharmaceuticals Inc. | 2 | solution | Generic drugs (ANDA) | May 4, 2018 |
| Amneal Pharmaceuticals NY LLC | 2 | solution | Generic drugs (ANDA) | March 17, 2020 |
| Apotex Corp. | 2 | solution | Generic drugs (ANDA) | March 1, 2019 |
| NorthStar RxLLC | 2 | solution; solution/ drops | Generic drugs (ANDA) | December 1, 2023 |
| PharmPak, Inc. | 2 | tablet | Generic drugs (ANDA) | July 10, 2019 |
| Proficient Rx LP | 2 | solution; solution/ drops | Generic drugs (ANDA) | December 7, 2022 |
| Rising Pharma Holdings, Inc. | 2 | solution | Generic drugs (ANDA) | July 1, 2022 |
| Sandoz Inc | 2 | solution/ drops | Authorized generics (NDA) | October 3, 2016 |
| St. Mary's Medical Park Pharmacy | 2 | solution | Generic drugs (ANDA) | January 29, 2025 |
| Allergan, Inc. | 1 | solution/ drops | New drug applications (NDA) | August 1, 1993 |
| Allergan, Inc. | 1 | solution/ drops | New drug applications (NDA) | May 19, 2010 |
| Armas Pharmaceuticals Inc. | 1 | solution/ drops | Generic drugs (ANDA) | October 14, 2023 |
| Bausch & Lomb Americas Inc. | 1 | suspension | New drug applications (NDA) | January 9, 2026 |
| Bryant Ranch Prepack | 1 | solution | Generic drugs (ANDA) | May 14, 2004 |
| Bryant Ranch Prepack | 1 | solution | Generic drugs (ANDA) | May 14, 2004 |
| Bryant Ranch Prepack | 1 | solution | Generic drugs (ANDA) | May 14, 2004 |
| Dr. Reddy's Laboratories Limited | 1 | tablet, film coated | Generic drugs (ANDA) | March 5, 2014 |
| Fonseca Biosciences, LLC | 1 | suspension | New drug applications (NDA) | May 1, 2026 |
| Gland Pharma Limited | 1 | solution/ drops | Generic drugs (ANDA) | March 30, 2020 |
| Major Pharmaceuticals | 1 | solution/ drops | Generic drugs (ANDA) | November 11, 2024 |
| Micro Labs Limited | 1 | solution | Generic drugs (ANDA) | October 15, 2026 |
| NorthStar Rx LLC | 1 | solution/ drops | Generic drugs (ANDA) | October 4, 2017 |
| Novadoz Pharmaceuticals LLC | 1 | tablet, film coated | Generic drugs (ANDA) | July 21, 2018 |
| Sagent Pharmaceuticals | 1 | injection, solution | Generic drugs (ANDA) | March 24, 2008 |
| Sandoz Inc | 1 | solution/ drops | Authorized generics (NDA) | May 7, 2003 |
| Sola Pharmaceuticals, LLC | 1 | solution/ drops | Generic drugs (ANDA) | April 30, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 52 | 43.3% |
| Solution/ drops | 41 | 34.2% |
| Tablet, film coated | 14 | 11.7% |
| Tablet | 5 | 4.2% |
| Suspension | 5 | 4.2% |
| Injection, solution | 1 | 0.8% |
| Tablet, coated | 1 | 0.8% |
| Suspension/ drops | 1 | 0.8% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.